VXX News 39.56 05/06/2014 05:38:35 VIX Short-Term Futures ETN

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
VIX Short-Term Futures ETN Ipath (VXX) 39.56 $VXX

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 1.10% Yesterday
Comtex SmarTrend(R) - Mon May 05, 4:02PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $39.55 to a high of $40.85. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $39.73 on volume of 22.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound after Yesterday's 1.10% Sell Off
Comtex SmarTrend(R) - Mon May 05, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $39.55 to a high of $40.85. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $39.73 on volume of 22.0 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Rebound After Yesterday's Selloff of 1.83%
Comtex SmarTrend(R) - Tue Apr 29, 3:39PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.15 to a high of $40.91. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $40.72 on volume of 25.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Falls 1.85% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Mon Apr 21, 3:46PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.85 to a high of $41.73. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $41.62 on volume of 21.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Decline of 1.85%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Apr 21, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.85 to a high of $41.73. Yesterday, the shares fell 1.8%, which took the trading range below the 3-day low of $41.62 on volume of 21.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

iPATH S&P 500 VIX Short-Term Futures ETN Falls 3.57% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Apr 16, 3:45PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.28 to a high of $43.71. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $43.33 on volume of 33.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Look for Shares of iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound after Yesterday's 3.57% Sell Off
Comtex SmarTrend(R) - Wed Apr 16, 3:44PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.28 to a high of $43.71. Yesterday, the shares fell 3.6%, which took the trading range below the 3-day low of $43.33 on volume of 33.7 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

After Yesterday's Rally of 6.00% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Apr 10, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.96 to a high of $43.60. Yesterday, the shares gained 6.0%, which took the trading range above the 3-day high of $43.41 on volume of 47.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

3 Signs the Dow's Drop Is Just a Dip
Dan Caplinger, The Motley Fool - Motley Fool - Mon Apr 07, 8:03PM CDT
The Dow Jones Industrials fell 166 points Monday, following up on Friday's similar losses and getting many investors fearful about the future of stocks. With the popular "sell in May" indicator just a few weeks away from triggering its seasonal...

iPATH S&P 500 VIX Short-Term Futures ETN Set to Possibly Pullback After Yesterday's Rally of 2.07%
Comtex SmarTrend(R) - Fri Apr 04, 3:43PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $40.25 to a high of $42.36. Yesterday, the shares gained 2.1%, which took the trading range above the 3-day high of $42.06 on volume of 48.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Don't Let These ETFs Fool You - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Tue Apr 01, 10:45AM CDT
Most ETFs are simple and transparent but investors need to be aware of a few potential pitfalls with some ETFs.

After Yesterday's Decline of 3.21%, iPATH S&P 500 VIX Short-Term Futures ETN Offers Investors Better Value
Comtex SmarTrend(R) - Mon Mar 31, 3:41PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $42.11 to a high of $43.15. Yesterday, the shares fell 3.2%, which took the trading range below the 3-day low of $43.30 on volume of 28.2 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.

Dow Correction: Why You Shouldn't Panic Over Market Volatility
Dan Caplinger, The Motley Fool - Motley Fool - Wed Mar 26, 3:30PM CDT
On Wednesday, the Dow Jones Industrials lost almost 100 points, finishing near the day's lows as investors worried about a variety of factors that could hurt the market's future prospects. That range of issues runs from the threat of war in...

'Fast Money' Recap: Opportunities in Technology
at The Street - Wed Mar 26, 4:00AM CDT
The trading panel discussed some familar names -- IBM, Hewlett-Packard and Qualcomm.

Watch for iPATH S&P 500 VIX Short-Term Futures ETN to Potentially Rebound After Falling 3.94% Yesterday
Comtex SmarTrend(R) - Tue Mar 18, 3:44PM CDT
iPATH S&P 500 VIX Short-Term Futures ETN (NYSE:VXX) traded in a range yesterday that spanned from a low of $43.31 to a high of $44.41. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $43.62 on volume of 34.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Unicycive Faces Legal Heat Amid Stock Tumble

Updated Category News Views 22

Unicycive Therapeutics' Rough Ride In this wild market, sometimes even the most seasoned investors get blindsided. Unicycive Therapeutics (NASDAQ: UNC) shareholders are currently caught in a storm with their stock nose-diving by 39.1% on June 30, 2026. It's like being taken to the cleaners without the decency of a warning. Failed Expectations & FDA Blues Here's the...

Continue Reading
Savvy Moves: Avoiding Pitfalls When Buying Used Vans

Updated Category News Views 14

When you're eyeing a used work van, don't just kick the tires and jot down the mileage—there's a whole backyard BBQ checklist you need to chew through. Tony Collichio, the work van guru from Spencerport, lays it down for us, highlighting key questions to ask before pulling out the checkbook. And let me tell you, these aren’t your everyday 'how does it drive?' queries....

Continue Reading
Effective Youth Hockey Skills: Mastering the Basics

Updated Category News Views 35

Laying Down the Tracks: Essential Foundations in Hockey When it comes to developing youth hockey skills, there's no magic formula or flashy trick that'll make overnight stars out of young players. According to HelloNation's recent piece featuring hockey development expert Dave Maksymiu, it’s all about going back to basics. This seems to be the memo often missed by...

Continue Reading
Parents Nationwide Rally for Youth Online Safety Imperative

Updated Category News Views 35

Ringing the Alarm on Digital Dangers Like trying to herd cats on a wild day at the market, keeping teens safe online is a task as tricky as they come. And now, with over 20,000 parents joining forces, it seems there's a real demand out there for some much-needed consistency in online safeguards across all social media platforms. This isn't just about one platform or...

Continue Reading
FDA Nod for Subcutaneous SKYRIZI in Crohn's Disease

Updated Category News Views 48

AbbVie's Injection Makes Waves in Crohn's Treatment Here's a bit of medicine shake-up for you. AbbVie just snagged FDA approval for its subcutaneous SKYRIZI—specifically designed for adults battling moderately to severely active Crohn's disease. This news isn't just a blip on the radar; it's significant for patients and the healthcare landscape. We're talking about new...

Continue Reading
DCK Reveals Versatile Battery-Powered Garden Tools in 2026

Updated Category News Views 65

Battery-Powered Revolution in Louisville The treadmill of lawn care just took a high-tech spin with DCK Tools strutting their stuff at Equip Exposition 2026. Unrolled at the Kentucky Exposition Center, the event from October 21 to 23 was brimming with their battery-powered wares that aim to take the grunt out of yard work. Game-Changing Range of Garden Tools DCK's decked...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 0

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 143

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 0

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
CapCut's AI Tools Reshape Video Content Creation

Updated Category News Views 40

AI Revolution in Marketing Content: CapCut Takes Lead It's like the old guard of marketing has hitched a ride on a rocket. In 2026, CapCut has stomped into the limelight with Better Business Advice giving them a nod for their prowess in AI-driven content creation. This isn't some passing trend; it's a seismic shift in how businesses craft their messages. CapCut ain't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Neurocrine Biosciences Unveils Potential of CRENESSITY™ for CAH

Updated Category News Views 379

Overview of CRENESSITY™ Approval Neurocrine Biosciences, Inc. announced a significant breakthrough with the FDA's approval of CRENESSITY™ (crinecerfont), marking the first new treatment for classic congenital adrenal hyperplasia (CAH) in nearly seven decades. This innovative therapy represents a profound shift in the management of this serious genetic condition that...

Continue Reading
Solidion Tech Hits Pause on S-1 Amid Market Forces

Updated Category News Views 15

Solidion's Strategic Withdrawal: Timing or Tactical Move? Solidion Technology, for all intents and purposes, just took a step back. Now, before we wave our hands in panic, let's stew over why the withdrawal of their S-1 registration might actually be more of a tactical retreat than a sign of sinking ship. They're pulling the plug on this specific filing—not because...

Continue Reading
Exploring the Future of the Couriers Market and AI's Role

Updated Category News Views 461

The Promising Growth of the Global Couriers Market The couriers market is on the brink of transformation, with expected growth of USD 115.9 billion from 2024 to 2028. This remarkable expansion is being driven primarily by advancements in technology and the integration of artificial intelligence (AI) in various logistics processes. During this period, the market is...

Continue Reading
Survey Reveals Growing Advisor Interest in Private Market Allocations

Updated Category News Views 213

Insights Into Private Market Allocations by Advisors A recent survey highlights a transformative trend among investment advisors regarding their allocation strategies. According to the findings by Hamilton Lane, nearly one-third of advisors are aiming to allocate 20% or more of their clients' portfolios to private markets in the near future. This shows a significant...

Continue Reading
Zack Kass: Driving AI Innovation at International Talent Conference

Updated Category News Views 165

Zack Kass: A Visionary Leader in AI Zack Kass, a prominent AI strategist and executive business advisor, is set to be the keynote speaker at the 2026 International Conference & Exposition organized by the Association for Talent Development. This global event, at the Los Angeles Convention Center, is expected to attract thousands of attendees aiming to explore the latest...

Continue Reading